@article{27795,
  author = {Chowdhry S and Shukla A and D'Souza P and Dhali T and Jaiswal P},
  title = {Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept.},
  abstract = {<p>Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.</p>
},
  year = {2016},
  journal = {International journal of mycobacteriology},
  volume = {5},
  pages = {223-5},
  issn = {2212-554X},
  url = {http://www.sciencedirect.com/science/article/pii/S2212553116000212},
  doi = {10.1016/j.ijmyco.2016.02.002},
  language = {eng},
}